Benzquinamide
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate | |
| Clinical data | |
| Trade names | Promecon, Quantril, Emete-Con |
| Licence data | US FDA:link |
| Routes of administration | Suppository, injection |
| Identifiers | |
| CAS Number |
63-12-7 |
| ATC code | None |
| IUPHAR/BPS | 7124 |
| DrugBank |
DB00767 |
| ChemSpider |
2252 |
| UNII |
0475EA27Q3 |
| KEGG |
D00243 |
| ChEMBL |
CHEMBL1201250 |
| Chemical data | |
| Formula | C22H32N2O5 |
| Molar mass | 404.5 g/mol |
| |
| |
| | |
Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.[1][2]
References
This article is issued from Wikipedia - version of the Saturday, January 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
